FDA Drugs recall ·
SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL)… recall
- Recall number
- D-0757-2026
- Date
- (initiated July 29, 2026)
- Company / brand
- Apollo Care, LLC
3801 Mojave Ct Ste 101, Columbia, MO, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 4,250 vials.
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
Why was it recalled?
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
Distribution
Nationwide within the U.S
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0757-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.